Spyre Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
SYRE$103.86+7.5%Stored close · as of Nov 6, 2026
Contents
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.